Quantum-Si (QSI) Non-Current Deffered Revenue (2020 - 2021)

Quantum-Si (QSI) reported Non-Current Deffered Revenue of $4.0 million for Q1 2021, little changed quarter-over-quarter from $4.0 million in Q4 2020.

Quantum-Si (QSI) Non-Current Deffered Revenue (2020 - 2021) Analysis & Trends

Quantum-Si (QSI) has 2 years of Non-Current Deffered Revenue data on file, last reported at $4.0 million in Q1 2021.

Non-Current Deffered Revenue for Q1 2021 came in at $4.0 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2021 was $4.0 million (changed N/A YoY), and the FY2020 annual result was $4.0 million, changed N/A from the prior year.
Non-Current Deffered Revenue was little changed at $4.0 million in Q1 2021 per QSI's latest filing, from $4.0 million in the prior quarter.
Over five years, Non-Current Deffered Revenue peaked at $4.0 million in Q3 2020 and troughed at $4.0 million in Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Deffered Revenue (Qtr)
1	Abbott Laboratories	152.92 Bn	146.27 Bn	6.27 Bn	-
2	Stryker	119.50 Bn	116.62 Bn	3.81 Bn	-
3	Medtronic	102.71 Bn	94.54 Bn	5.76 Bn	-
4	Boston Scientific	69.72 Bn	68.51 Bn	3.61 Bn	-
5	Edwards Lifesciences	49.24 Bn	45.57 Bn	1.29 Bn	-
6	GE HealthCare Technologies	29.74 Bn	27.67 Bn	1.98 Bn	-
7	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	512.79 Mn
8	Dexcom	28.96 Bn	27.84 Bn	750.30 Mn	-
9	Steris	20.31 Bn	19.88 Bn	697.10 Mn	-
10	Quantum-Si	203.85 Mn	76.51 Mn	74,000.00	-

Download Data